These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 25944395)

  • 1. Dosimetric comparison of brachyablation and stereotactic ablative body radiotherapy in the treatment of liver metastasis.
    Pennington JD; Park SJ; Abgaryan N; Banerjee R; Lee PP; Loh C; Lee E; Demanes DJ; Kamrava M
    Brachytherapy; 2015; 14(4):537-42. PubMed ID: 25944395
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protons offer reduced normal-tissue exposure for patients receiving postoperative radiotherapy for resected pancreatic head cancer.
    Nichols RC; Huh SN; Prado KL; Yi BY; Sharma NK; Ho MW; Hoppe BS; Mendenhall NP; Li Z; Regine WF
    Int J Radiat Oncol Biol Phys; 2012 May; 83(1):158-63. PubMed ID: 22245197
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multicentre treatment planning inter-comparison in a national context: The liver stereotactic ablative radiotherapy case.
    Esposito M; Maggi G; Marino C; Bottalico L; Cagni E; Carbonini C; Casale M; Clemente S; D'Alesio V; Fedele D; Giglioli FR; Landoni V; Martinotti A; Nigro R; Strigari L; Villaggi E; Mancosu P
    Phys Med; 2016 Jan; 32(1):277-83. PubMed ID: 26498378
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Critical appraisal of volumetric modulated arc therapy in stereotactic body radiation therapy for metastases to abdominal lymph nodes.
    Bignardi M; Cozzi L; Fogliata A; Lattuada P; Mancosu P; Navarria P; Urso G; Vigorito S; Scorsetti M
    Int J Radiat Oncol Biol Phys; 2009 Dec; 75(5):1570-7. PubMed ID: 19880261
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stereotactic ablative radiotherapy (SABR) as primary, adjuvant, consolidation and re-treatment option in pancreatic cancer: scope for dose escalation and lessons for toxicity.
    Goldsmith C; Plowman PN; Green MM; Dale RG; Price PM
    Radiat Oncol; 2018 Oct; 13(1):204. PubMed ID: 30340643
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stereotactic ablative body radiation therapy with dynamic conformal multiple arc therapy for liver tumors: optimal isodose line fitting to the planning target volume.
    Oku Y; Takeda A; Sanuki N; Sudo Y; Oooka Y; Aoki Y; Shimouchi Y; Nishina R; Nomura K; Eriguchi T; Kunieda E
    Pract Radiat Oncol; 2014; 4(1):e7-e13. PubMed ID: 24621435
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypofractionated image-guided breath-hold SABR (stereotactic ablative body radiotherapy) of liver metastases--clinical results.
    Boda-Heggemann J; Dinter D; Weiss C; Frauenfeld A; Siebenlist K; Attenberger U; Ottstadt M; Schneider F; Hofheinz RD; Wenz F; Lohr F
    Radiat Oncol; 2012 Jun; 7():92. PubMed ID: 22710033
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Image-based 3D treatment planning for vaginal cylinder brachytherapy: dosimetric effects of bladder filling on organs at risk.
    Hung J; Shen S; De Los Santos JF; Kim RY
    Int J Radiat Oncol Biol Phys; 2012 Jul; 83(3):980-5. PubMed ID: 22138458
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stereotactic ablative radiotherapy for ultra-central lung tumors: prioritize target coverage or organs at risk?
    Murrell DH; Laba JM; Erickson A; Millman B; Palma DA; Louie AV
    Radiat Oncol; 2018 Apr; 13(1):57. PubMed ID: 29606150
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative analysis between interstitial brachytherapy and stereotactic body irradiation for local ablation in liver malignancies.
    Hass P; Mohnike K; Kropf S; Brunner TB; Walke M; Albers D; Petersen C; Damm R; Walter F; Ricke J; Powerski M; Corradini S
    Brachytherapy; 2019; 18(6):823-828. PubMed ID: 31522972
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of Monte Carlo algorithm for compliance with RTOG 0915 dosimetric criteria in peripheral lung cancer patients treated with stereotactic body radiotherapy.
    Pokhrel D; Sood S; Badkul R; Jiang H; McClinton C; Lominska C; Kumar P; Wang F
    J Appl Clin Med Phys; 2016 May; 17(3):277-293. PubMed ID: 27167284
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety and Efficacy of Stereotactic Ablative Radiation Therapy for Renal Cell Carcinoma Extracranial Metastases.
    Wang CJ; Christie A; Lin MH; Jung M; Weix D; Huelsmann L; Kuhn K; Meyer J; Desai N; Kim DWN; Pedrosa I; Margulis V; Cadeddu J; Sagalowsky A; Gahan J; Laine A; Xie XJ; Choy H; Brugarolas J; Timmerman R; Hannan R
    Int J Radiat Oncol Biol Phys; 2017 May; 98(1):91-100. PubMed ID: 28587057
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of heart and coronary artery doses associated with intensity-modulated radiotherapy versus three-dimensional conformal radiotherapy for distal esophageal cancer.
    Kole TP; Aghayere O; Kwah J; Yorke ED; Goodman KA
    Int J Radiat Oncol Biol Phys; 2012 Aug; 83(5):1580-6. PubMed ID: 22284687
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low Hepatic Toxicity in Primary and Metastatic Liver Cancers after Stereotactic Ablative Radiotherapy Using 3 Fractions.
    Bae SH; Kim MS; Jang WI; Cho CK; Yoo HJ; Kim KB; Han CJ; Park SC; Lee DH
    J Korean Med Sci; 2015 Aug; 30(8):1055-61. PubMed ID: 26240482
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dosimetric comparison of CT-guided iodine-125 seed stereotactic brachytherapy and stereotactic body radiation therapy in the treatment of NSCLC.
    Li R; Zhang Y; Yuan Y; Lin Q; Dai J; Xu R; Hu X; Han M
    PLoS One; 2017; 12(11):e0187390. PubMed ID: 29121047
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dosimetric comparison of liver tumour radiotherapy in all respiratory phases and in one phase using 4DCT.
    Gabryś D; Kulik R; Trela K; Ślosarek K
    Radiother Oncol; 2011 Sep; 100(3):360-4. PubMed ID: 21974916
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical impact of removing respiratory motion during liver SABR.
    Gargett M; Haddad C; Kneebone A; Booth JT; Hardcastle N
    Radiat Oncol; 2019 Jun; 14(1):93. PubMed ID: 31159840
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dosimetric Consequences of 3D Versus 4D PET/CT for Target Delineation of Lung Stereotactic Radiotherapy.
    Siva S; Chesson B; Callahan JW; Hardcastle N; Crawford L; Antippa P; Wright G; MacManus MP; Hicks RJ; Kron T; Ball DL
    J Thorac Oncol; 2015 Jul; 10(7):1112-5. PubMed ID: 26134229
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multi-institutional comparison of treatment planning using stereotactic ablative body radiotherapy for hepatocellular carcinoma - benchmark for a prospective multi-institutional study.
    Eriguchi T; Takeda A; Oku Y; Ishikura S; Kimura T; Ozawa S; Nakashima T; Matsuo Y; Nakamura M; Matsumoto Y; Yamazaki S; Sanuki N; Ito Y
    Radiat Oncol; 2013 May; 8():113. PubMed ID: 23641879
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparative planning study for lung SABR between tri-Co-60 magnetic resonance image guided radiation therapy system and volumetric modulated arc therapy.
    Park JM; Park SY; Kim HJ; Wu HG; Carlson J; Kim JI
    Radiother Oncol; 2016 Aug; 120(2):279-85. PubMed ID: 27401404
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.